These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35345474)

  • 21. [Clinical analysis of sepsis with extensively drug resistant Gram-negative bacteria in intensive care unit treated with polymyxin B-based combination therapy].
    Zhao S; Yan L; Wang C; Peng M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Feb; 32(2):150-154. PubMed ID: 32274997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic Activity and Mechanism of Sanguinarine with Polymyxin B against Gram-Negative Bacterial Infections.
    Qiao L; Zhang Y; Chen Y; Chi X; Ding J; Zhang H; Han Y; Zhang B; Jiang J; Lin Y
    Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.
    Savoldi A; Carrara E; Piddock LJV; Franceschi F; Ellis S; Chiamenti M; Bragantini D; Righi E; Tacconelli E
    BMC Infect Dis; 2021 Jun; 21(1):545. PubMed ID: 34107899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
    Lima EM; Cid PA; Beck DS; Pinheiro LHZ; Tonhá JPS; Alves MZO; Lourenço ND; Santos RQ; Asensi MD; Marques JA; Bandeira CS; Rodrigues CAS; Gomes Junior SCS; Gomes MZR;
    Antimicrob Resist Infect Control; 2020 Aug; 9(1):132. PubMed ID: 32795380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology, Susceptibility, and Risk Factors Associated with Mortality in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Abdominal Solid Organ Transplant Recipients: A Retrospective Cohort Study.
    Wu D; Chen C; Liu T; Jia Y; Wan Q; Peng J
    Infect Dis Ther; 2021 Mar; 10(1):559-573. PubMed ID: 33611687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods.
    Nelson BC; Eiras DP; Gomez-Simmonds A; Loo AS; Satlin MJ; Jenkins SG; Whittier S; Calfee DP; Furuya EY; Kubin CJ
    Antimicrob Agents Chemother; 2015 Nov; 59(11):7000-6. PubMed ID: 26324272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel Risk Predictive Scoring Model for Predicting Subsequent Infection After Carbapenem-Resistant Gram-Negative Bacteria Colonization in Hematological Malignancy Patients.
    Wu Q; Qian C; Yin H; Liu F; Wu Y; Li W; Xia L; Ma L; Hong M
    Front Oncol; 2022; 12():897479. PubMed ID: 35651791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
    Ting SW; Lee CH; Liu JW
    J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical Analysis of Colistin Sulfate in the Treatment of Hematonosis Infected by Multidrug-Resistant Gram-Negative Bacteria].
    Wu YB; Jiang SS; Wu YX; Li DY; Li Q; Wang X; Liu B; Bao HY; Hu XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1878-1884. PubMed ID: 38071076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymyxin B/Tigecycline Combination vs. Polymyxin B or Tigecycline Alone for the Treatment of Hospital-Acquired Pneumonia Caused by Carbapenem-Resistant
    Chang K; Wang H; Zhao J; Yang X; Wu B; Sun W; Huang M; Cheng Z; Chen H; Song Y; Chen P; Chen X; Gan X; Ma W; Xing L; Wang Y; Gu X; Zou X; Cao B
    Front Med (Lausanne); 2022; 9():772372. PubMed ID: 35755062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effect of Polymyxin B and Tigecycline to overcome Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae.
    Tian Y; Zhang Q; Wen L; Chen J
    Microbiol Spectr; 2021 Oct; 9(2):e0015221. PubMed ID: 34704782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria.
    Rivera-Villegas HO; Martinez-Guerra BA; Garcia-Couturier R; Xancal-Salvador LF; Esteban-Kenel V; Jaimes-Aquino RA; Mendoza-Rojas M; Cervantes-Sánchez A; Méndez-Ramos S; Alonso-Montoya JE; Munguia-Ramos D; Tamez-Torres KM; Roman-Montes CM; Rajme-Lopez S; Martínez-Gamboa A; Bobadilla-Del-Valle M; Gonzalez-Lara MF; Sifuentes-Osornio J; Ponce-de-Leon A
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children.
    Jia X; Yin Z; Zhang W; Guo C; Du S; Zhang X
    Front Pharmacol; 2022; 13():902054. PubMed ID: 35712713
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience.
    Shi R; Fu Y; Gan Y; Wu D; Zhou S; Huang M
    Front Pharmacol; 2023; 14():1222044. PubMed ID: 37719858
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation.
    Liu Y; Liu Y; Liu Y; Chen X; Jia Y
    Heliyon; 2023 Apr; 9(4):e15285. PubMed ID: 37101646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of antibiotic combinations.
    Carrara E; Savoldi A; Piddock LJV; Franceschi F; Ellis S; Sharland M; Brink AJ; Harris PNA; Levy-Hara G; Rohit A; Tsioutis C; Zayyad H; Giske C; Chiamenti M; Bragantini D; Righi E; Gorska A; Tacconelli E
    Clin Microbiol Infect; 2022 Jan; 28(1):66-72. PubMed ID: 33975010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infection control management and surveillance of carbapenem-resistant Gram-negative bacteria in hematopoietic stem cell recipients.
    Baier C; Beck M; Panagiota V; Lueck C; Kharazipour D; Hintze SC; Bollin R; Ebadi E; Ziesing S; Eder M; Bange FC; Beutel G
    Antimicrob Resist Infect Control; 2019; 8():160. PubMed ID: 31649817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination Regimens with Colistin Sulfate versus Colistin Sulfate Monotherapy in the Treatment of Infections Caused by Carbapenem-Resistant Gram-Negative Bacilli.
    Hao M; Yang Y; Guo Y; Wu S; Hu F; Qin X
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The place of ceftazidime/avibactam and ceftolozane/tazobactam for therapy of haematological patients with febrile neutropenia.
    Clerici D; Oltolini C; Greco R; Ripa M; Giglio F; Mastaglio S; Lorentino F; Pavesi F; Farina F; Liberatore C; Castiglion B; Tassan Din C; Bernardi M; Corti C; Peccatori J; Scarpellini P; Ciceri F; Castagna A
    Int J Antimicrob Agents; 2021 Jun; 57(6):106335. PubMed ID: 33838223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.